Notice of Effectiveness

Oruka Therapeutics, Inc. Filed 2026-08-27 Acc 9999999995-26-002787

Documents 1

2026-09-01 4 Chief Operating Officer sold 5,000 shares at an average $91.82 ($459,101)
2026-08-28 424B5 Prospectus
2026-08-27 EFFECT Notice of Effectiveness
2026-08-25 4 Chief Commercial Officer acquired 100,000 shares (grant or award)
2026-08-25 3 Initial Statement of Ownership
2026-08-24 8-K Executive or director change
2026-04-10 EFFECT Notice of Effectiveness

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…